News
Bird Flu Threat Still Looms, But HHS Just Canceled a Moderna Contract That Could Prepare for It
Messenger RNA technology offers a faster way to develop vaccines to address or prepare for pandemics, and Moderna’s vaccine candidate for avian influenza is on track for Phase 3 testing. But the Department of Health and Human Services has canceled a $590 million contract to support Moderna's pivotal trial.
Over the past three years, avian influenza (H5N1) has spread around the U.S. and affected many species of birds and mammals, ...
Highly pathogenic avian influenza viruses like H5N1, H5N6, and H7N9 pose an evolving global threat due to their capacity to ...
The fear of bird flu should not deter people from consuming poultry products as long as they are cooked properly and handled ...
Cambodia's ministry of health has reported its fourth fatal human H5N1 avian flu case of the year, which involves an ...
While bird flu has been around for decades, the discovery in 2024 that the deadly pathogen spread from a wild bird to a cow surprised virus watchers, according to news officials. In just over ...
Today, the same problem exists in animals for H5N1 bird flu, where the virus spreads through ... which “detects genetic material from a pathogen or abnormal cell sample,” to come back.
U.S. Health Secretary Robert F. Kennedy Jr. says he has talked to Canadian health officials about sparing a flock of ...
News-Medical.Net on MSN5d
Genomic analysis reveals how bird flu jumped from wild birds to poultry and peopleResearchers identified a novel genotype (D1.1) of highly pathogenic avian influenza H5N1 spreading among wild birds, poultry, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback